Thursday, 25 April 2019
Independence Chief Medical Officer Dr. Richard Snyder participates in state press conference about opioid prescription processes
Monday, 15 October 2018
Monday, 24 September 2018
Independence Blue Cross to place additional restrictions on OxyContin® and Oxycodone ER to help reduce opioid use and abuse
Tuesday, 07 August 2018
Independence Blue Cross (Independence) announced that as part of its commitment to helping reduce opioid misuse and overprescribing, it is placing new restrictions on OxyContin® and Oxycodone ER. These products will be removed from some formularies and will require a new prior authorization on others, effective October 1. In addition, Xtampza® XR,...
Independence Blue Cross to sponsor opioid addiction forum with Delaware County Chamber of Commerce on August 21
Monday, 06 August 2018
Thursday, 12 July 2018
Efforts have led to reduced opioid use, prescriptions, and abuseIn conjunction with a national Health of America report by the Blue Cross Blue Shield Association (BCBSA) about opioid use, Independence Blue Cross (Independence) is reporting the success it has achieved in addressing one of nation’s top health crises. The highlights of these results include: Reducing opioid use and prescriptions: Since 2014,...
Friday, 18 May 2018
Wednesday, 02 May 2018
On National Prescription Drug Take Back Day, free grassroots public event unites hundredsSince 2015, there has been a 50 percent increase in drug-related deaths in Bucks County, Pennsylvania — one of the highest increases across the state....
Blue Cross Blue Shield Association and Independence Blue Cross support opioid prevention and treatment efforts
Friday, 06 April 2018
Efforts include policy that recommends not prescribing opioids as first or second line of pain therapy, and limiting initial opioid scripts to five daysThe Blue Cross Blue Shield Association (BCBSA) National Council of Physician and Pharmacist Executives announced today that it has adopted a professional standard that opioids should not be prescribed as first or second lines of pain therapy in most clinical situations....
Tuesday, 20 February 2018
Action aims to remove access barriers, save lives, and further combat the opioid abuse epidemicPhiladelphia, PA — Independence Blue Cross (Independence) announced that as of March 1 it is removing member cost sharing for injectable and nasal spray formulations of naloxone and Narcan (a brand of naloxone). Independence is one of the first Blue plans in the country to implement this change....